Evolus (EOLS) Return on Equity [ROE] (2018 - 2024)
Evolus (EOLS) posted Return on Equity [ROE] of -883.63% for Q4 2024, down 443.54 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Return on Equity [ROE] (2018 - 2024) Analysis & Trends
For FY2022, Evolus' Return on Equity [ROE] came in at -148.27%, up 901.52 percentage points from FY2021.
- Annual Return on Equity [ROE] shows a four-year change of +911.95 percentage points (FY2018 to FY2022).
- In prior years, Evolus' Return on Equity [ROE] was -1049.79% in FY2021 (+3966.77 pp), -5016.56% in FY2020 (-4906.65 pp), -109.90% in FY2019 (+950.32 pp) and -1060.22% in FY2018.
- The Q4 2024 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q2 2018.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2020, with a gain of 132.34 percentage points; the weakest was Q1 2023, with a drop of 471.43 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Evolus | 528.11 Mn | 335.80 Mn | 57.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -883.63% |
| Sep 30, 2024 | -440.09% |
| Jun 30, 2024 | -281.87% |
| Mar 31, 2023 | -563.52% |
| Dec 31, 2022 | -303.27% |
| Sep 30, 2022 | -203.39% |
| Jun 30, 2022 | -134.13% |
| Mar 31, 2022 | -92.08% |
| Dec 31, 2021 | -52.22% |
| Sep 30, 2021 | -136.90% |
| Jun 30, 2021 | -202.98% |
| Sep 30, 2020 | -169.83% |
| Jun 30, 2020 | -155.08% |
| Mar 31, 2020 | -139.08% |
| Dec 31, 2019 | -186.60% |
| Sep 30, 2019 | -302.17% |
| Jun 30, 2019 | -124.96% |
| Mar 31, 2019 | -64.70% |
| Dec 31, 2018 | -52.26% |
| Sep 30, 2018 | -45.11% |
API Access
Evolus Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();